VCI Global Secures Its First IPO Consultancy Deal in 2024 With a Singapore-Based Fin-MedTech Medical Group
KUALA LUMPUR, Malaysia, Jan. 23, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ:VCIG) (“VCI Global”, or the “Company”) has been engaged by a Singapore-based Fin-MedTech Medical Group (the “Medical Group”) as its initial public offering (“IPO”) consultant for its intended IPO on Nasdaq which is expected to be completed in 2024/2025.
Related news for (VCIG)
- VCI Global to Announce First Half 2025 Financial Results on October 6, 2025
- 24/7 Market News Snapshot 01 October, 2025 – VCI Global Limited Ordinary Share (NASDAQ:VCIG)
- MoBot’s Stock Market Highlights – 10/01/25 08:00 AM
- 24/7 Market News Snapshot 01 October, 2025 – VCI Global Limited Ordinary Share (NASDAQ:VCIG)
- VCI Global Powers Food Security Technology Company Agroz (AGRZ) to Nasdaq: Successful IPO Pricing and Trading Begins Today